A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment

NCT02387814 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency

Interventions

DRUG: Abemaciclib

Sponsor

Eli Lilly and Company